Literature DB >> 20819636

Inflammatory airway features and hypothalamic-pituitary-adrenal axis function in asthmatic rats combined with chronic obstructive pulmonary disease.

Cui Cai1, Hong-Ying Zhang, Jing-Jing Le, Jing-Cheng Dong, Yan Cui, Chang-Qing Xu, Bao-Jun Liu, Jin-Feng Wu, Xiao-Hong Duan, Yu-Xue Cao.   

Abstract

BACKGROUND: Bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) are both inflammatory airway diseases with different characteristics. However, there are many patients who suffer from both BA and COPD. This study was to evaluate changes of inflammatory airway features and hypothalamic-pituitary-adrenal (HPA) axis function in asthmatic rats combined with COPD.
METHODS: Brown Norway (BN) rats were used to model the inflammatory airway diseases of BA, COPD and COPD + BA. These three models were compared and evaluated with respect to clinical symptoms, pulmonary histopathology, airway hyperresponsiveness (AHR), inflammatory cytokines and HPA axis function.
RESULTS: The inflammatory airway features and HPA axis function in rats in the COPD + BA model group were greatly influenced. Rats in this model group showed features of the inflammatory diseases BA and COPD. The expression of inflammatory cytokines in this model group might be up or downregulated when both disease processes are present. The levels of corticotrophin releasing hormone mRNA and corticosterone in this model group were both significantly decreased than those in the control group (P < 0.05).
CONCLUSIONS: BN rat can be used as an animal model of COPD + BA. By evaluating this animal model we found that the features of inflammation in rats in this model group seem to be exaggerated. The HPA axis functions in rats in this model group have been disturbed or impaired, which is prominent at the hypothalamic level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819636

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  Individual differences in glucocorticoid regulation: Does it relate to disease risk and resilience?

Authors:  Jasmine I Caulfield; Sonia A Cavigelli
Journal:  Front Neuroendocrinol       Date:  2019-11-04       Impact factor: 8.606

2.  Susceptibility to chronic mucus hypersecretion, a genome wide association study.

Authors:  Akkelies E Dijkstra; Joanna Smolonska; Maarten van den Berge; Ciska Wijmenga; Pieter Zanen; Marjan A Luinge; Mathieu Platteel; Jan-Willem Lammers; Magnus Dahlback; Kerrie Tosh; Pieter S Hiemstra; Peter J Sterk; Avi Spira; Jorgen Vestbo; Borge G Nordestgaard; Marianne Benn; Sune F Nielsen; Morten Dahl; W Monique Verschuren; H Susan J Picavet; Henriette A Smit; Michael Owsijewitsch; Hans U Kauczor; Harry J de Koning; Eva Nizankowska-Mogilnicka; Filip Mejza; Pawel Nastalek; Cleo C van Diemen; Michael H Cho; Edwin K Silverman; James D Crapo; Terri H Beaty; David A Lomas; Per Bakke; Amund Gulsvik; Yohan Bossé; Ma'en Obeidat; M A Obeidat; Daan W Loth; Lies Lahousse; Fernando Rivadeneira; Andre G Uitterlinden; Andre Hofman; Bruno H Stricker; Guy G Brusselle; Cornelia M van Duijn; Uilke Brouwer; Gerard H Koppelman; Judith M Vonk; Martijn C Nawijn; Harry J M Groen; Wim Timens; H Marike Boezen; Dirkje S Postma
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

3.  Comparative RNA-Seq Transcriptome Analysis on Pulmonary Inflammation in a Mouse Model of Asthma-COPD Overlap Syndrome.

Authors:  Pei Ma; Shuyi Li; Hui Yang; Jiqiao Yuan; Ziqian Zhang; Xuyu Li; Nan Fang; Mingbao Lin; Qi Hou
Journal:  Front Cell Dev Biol       Date:  2021-03-25

Review 4.  Appetite Regulation of TLR4-Induced Inflammatory Signaling.

Authors:  Yongxiang Li; Qingyan Jiang; Lina Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-24       Impact factor: 5.555

Review 5.  Immune-pineal axis: nuclear factor κB (NF-kB) mediates the shift in the melatonin source from pinealocytes to immune competent cells.

Authors:  Regina P Markus; Erika Cecon; Marco Antonio Pires-Lapa
Journal:  Int J Mol Sci       Date:  2013-05-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.